Sickle Cell Anemia is an inherited blood disorder. Normally, red blood cells are disc shaped, allowing the blood cell to move freely through blood vessels to deliver oxygen. People with sickle cell anemia have abnormal red blood cells, shaped like sickles or crescents. These red blood cells aren’t able to move freely through blood vessels, and can cause blockage that stops the blood flow to the nearby tissues. When this happens, oxygen isn’t delivered to the tissue and this can cause severe pain. Sickle cell anemia affects a person their whole life, and right now the only cure for sickle cell anemia is a hematopoietic stem cell transplantation.
Anemia, Sickle Cell Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Anemia, Sickle Cell below!
For more information on how to use Laverne, please read the How to Guide.
We have 1451 products for the study of Anemia, Sickle Cell that can be applied to Chromatin Immunoprecipitation, Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Anemia, Sickle Cell is also known as Cell Disease, Sickle, Disease, Hemoglobin S, Drepanocythemia, Haemoglobin S Disease, Hb Ss.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.